Abstract

Many hereditary diseases are characterized by region-specific toxicity, despite the fact that disease-linked proteins are generally ubiquitously expressed. The underlying basis of the region-specific vulnerability remains enigmatic. Here, we evaluate the fundamental features of mitochondrial and glucose metabolism in synaptosomes from four brain regions in basal and stressed states. Although the brain has an absolute need for glucose in vivo, we find that synaptosomes prefer to respire on non-glycolytic substrates, even when glucose is present. Moreover, glucose is metabolized differently in each brain region, resulting in region-specific “signature” pools of non-glycolytic substrates. The use of non-glycolytic resources increases and dominates during energy crisis, and triggers a marked region-specific metabolic response. We envision that disease-linked proteins confer stress on all relevant brain cells, but region-specific susceptibility stems from metabolism of non-glycolytic substrates, which limits how and to what extent neurons respond to the stress.

Highlights

  • Dysfunction of mitochondria (MT) is thought to be a primary contributor to aging and neurodegenerative disease, but its role is poorly understood [1,2]

  • In Alzheimer’s disease (AD), beta-amyloid toxicity is prominent in the hippocampus (HIP) [5,6], while toxicity observed in spinocerebellar ataxia type I (SCA1) manifests in the cerebellum (CBL) [7,8] and Huntington’s disease (HD) primarily targets the striatum (STR) [9,10]

  • In this report, we evaluated the bioenergetics of isolated synaptosomes to determine whether there were intrinsic region-specific differences among neurons, and, in parallel, measured the metabolic content of each dissected region using gas chromatography-coupled mass spectrometry (GC-MS)

Read more

Summary

Introduction

Dysfunction of mitochondria (MT) is thought to be a primary contributor to aging and neurodegenerative disease, but its role is poorly understood [1,2]. Region-specific cell death implies that mitochondrial dysfunction develops in response to a changing cellular metabolism [11,12], but the metabolic basis for regional toxicity remains one of the most puzzling features of neurodegenerative disease. Low glucose is a prominent feature of patients with neurodegeneration [13] and in animal models [14]. It is not obvious how a global suppression of glucose utilization accounts for the region-specific susceptibility to death. In the R6/2 HD mouse model, for example, glucose levels correlate directly with the cerebral blood volume (CBV) in regions of the brain, except in the affected STR and neocortex, where CBV is abnormally high [14]. The results imply that region-specific neuronal toxicity reflects inherent differences in metabolism of glucose rather than its availability

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call